ReviewClinical and experimental nephrology2020

Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia.

Satoru KuriyamaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.